Capital at risk
US equities
The US is a wonderfully innovative but surprisingly inefficient market, producing more growth companies than anywhere else. We aim to find you its exceptional opportunities.
Why invest in US growth equities?
Only a small handful of companies matter. Remarkably, just 90 out of nearly 26,000 firms listed in the US stock market created half the $35tn of gains made between 1926 and 2016. Putting your cash in a savings account would have given you a better return than holding the average company. It makes a nonsense of the efficient-market hypothesis that stocks trade at fair value. Instead, exceptional growth companies drive long-term market returns. Technological progress should ensure this continues.
How do we invest in US growth equities?
We have over a century’s experience backing US innovation. Today, more than 40 analysts from across the firm feed ideas to our US equities teams, providing a global perspective.
We’re dedicated to identifying future outliers. And we believe the potential upside of finding great companies and patiently holding onto them is nearly unlimited. This focused approach gives us a competitive edge.
US growth equities strategies
US Alpha
We focus on growing businesses across diverse opportunities that we hope will drive exceptional returns over time.
US Discovery
Transformative investing: Capturing early opportunities in small-to-mid cap firms with potential for growth and success.
US Equity Growth
Investing in innovative, high-growth US companies that we believe may be at the forefront of global change.
All our investment capabilities
Equity and multi-asset income
Seeking both dependable income and long-term capital growth.
Flexible growth
Portfolios containing a mix of firms focused on disruption, steady compounding and timely capital allocation.
High growth
Concentrated portfolios of fast-growth companies, typically holding between 25 and 50 stocks.
Important information
The information provided does not constitute an offer of or solicitation for purchase or sale of securities or provision of any investment services. Baillie Gifford does not currently have any funds that offer securities under a simplified prospectus for general offer or sale within Canada. No securities regulatory authority in Canada has reviewed or in any way passed upon this website or the merits of any investment available, and any representation to the contrary is an offence.
Persons resident or domiciled in Canada should consult with their professional advisers as to whether they require any governmental or other consents in order to enable them to trade.
You can read details of our Legal and Important Information here.
Trade Matching Statement
This Trade-Matching Statement is being provided in accordance with National Instrument 24-101 -"Institutional Trade Matching and Settlement" and Companion Policy 24-101 CP (the "National
Instrument"). It applies to all trades that are subject to the National Instrument. View the whole statement.